Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study.

导出 OA

翻译打印收藏纠错

第一作者： Fredrik H,Schjesvold

第一单位： Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway. fredrikschjesvold@gmail.com.

作者： Fredrik H,Schjesvold ^[1] ; Heinz,Ludwig ^[2] ; Sossana,Delimpasi ^[3] ; Pawel,Robak ^[4] ; Daniel,Coriu ^[5] ; Waldemar,Tomczak ^[6] ; Ludek,Pour ^[7] ; Ivan,Spicka ^[8] ; Meletios-Athanasios,Dimopoulos ^[9] ; Tamas,Masszi ^[10] ; Natalia G,Chernova ^[11] ; Anna,Sandberg ^[12] ; Marcus,Thuresson ^[12] ; Stefan,Norin ^[12] ; Nicolaas A,Bakker ^[12] ; Maria-Victoria,Mateos ^[13] ; Paul G,Richardson ^[14] ; Pieter,Sonneveld ^[15]

作者单位： Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway. fredrikschjesvold@gmail.com. ^[1] Department of Medicine I, Center for Medical Oncology and Hematology with Outpatient Department and Palliative Care, Wilhelminen Cancer Research Institute, Vienna. ^[2] Bone Marrow Transplantation Unit and Department of Hematology, Evangelismos Hospital, Athens, Greece. ^[3] Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic. ^[4] University of Medicine and Pharmacy "Carol Davila", Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania. ^[5] Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin. ^[6] Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic. ^[7] 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic. ^[8] Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. ^[9] Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary. ^[10] National Research Center for Haematology, Moscow, Russia. ^[11] Oncopeptides AB, Stockholm, Sweden. ^[12] Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain. ^[13] Dana-Farber Cancer Institute, Boston, MA. ^[14] Erasmus MC Cancer Institute, Rotterdam. ^[15]